{
    "organizations": [],
    "uuid": "97785e561b7c508356e117565161f69ee0cfe72c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-luye-pharma-group-says-ly03003-dru/brief-luye-pharma-group-says-ly03003-drug-approved-to-proceed-to-phase-iii-clinical-trials-in-china-idUSFWN1RM0U8",
    "ord_in_thread": 0,
    "title": "BRIEF-Luye Pharma Group Says LY03003 Drug Approved To Proceed To Phase III Clinical Trials In China",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10 (Reuters) - Luye Pharma Group Ltd:\n* LY03003 OBTAINED APPROVAL FROM CHINA FOOD AND DRUG ADMINISTRATION TO PROCEED TO PHASE III CLINICAL TRIALS IN CHINA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-10T13:42:00.000+03:00",
    "crawled": "2018-04-11T17:59:07.053+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "luye",
        "pharma",
        "group",
        "ltd",
        "ly03003",
        "obtained",
        "approval",
        "china",
        "food",
        "drug",
        "administration",
        "proceed",
        "phase",
        "iii",
        "clinical",
        "trial",
        "china",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}